Targeting sites of inflammation:Intercellular adhesion molecule-1 (ICAM-1) as a target for novel inflammatory therapies
Targeted drug delivery to sites of inflammation will provide effective, precise and safe therapeutic interventions for treatment of diverse disease conditions, by limiting toxic side effects and/or increasing drug action. Disease-site targeting is believed to play a major role in the enhanced effica...
| Egile nagusia: | |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Frontiers Media S.A.
2013-10-01
|
| Saila: | Frontiers in Pharmacology |
| Gaiak: | |
| Sarrera elektronikoa: | http://journal.frontiersin.org/Journal/10.3389/fphar.2013.00127/full |